301201 誠達藥業
按盤價 
21.580 -1.320 (-5.764%)
21.580 -1.320 (-5.764%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.792 | 4.051 | 7.762 | 20.345 | 29.765 |
| 總資產報酬率 ROA (%) | 1.665 | 3.809 | 7.087 | 16.500 | 22.424 |
| 投入資產回報率 ROIC (%) | 1.763 | 4.004 | 7.529 | 18.666 | 25.596 | 邊際利潤分析 |
| 銷售毛利率 (%) | 43.544 | 42.886 | 48.009 | 49.972 | 50.123 |
| 營業利潤率 (%) | 18.339 | 26.019 | 30.196 | 28.250 | 37.818 |
| 息稅前利潤/營業總收入 (%) | 16.083 | 23.299 | 27.876 | 28.389 | 38.856 |
| 淨利潤/營業總收入 (%) | 16.629 | 21.989 | 25.878 | 24.120 | 32.063 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 19.713 | 60.248 | 71.297 | 97.058 | 68.610 |
| 價值變動淨收益/利潤總額(%) | 67.846 | 40.119 | 33.021 | 0.000 | 0.000 |
| 營業外收支淨額/利潤總額(%) | -5.343 | -3.404 | -3.445 | -1.871 | -1.120 | 償債能力分析 |
| 流動比率 (X) | 9.276 | 9.578 | 16.876 | 1.529 | 2.485 |
| 速動比率 (X) | 8.462 | 8.817 | 15.305 | 0.824 | 1.655 |
| 資產負債率 (%) | 6.779 | 7.185 | 4.557 | 22.438 | 0.141 |
| 帶息債務/全部投入資本 (%) | 1.108 | 1.732 | 0.077 | 11.773 | 1.377 |
| 股東權益/帶息債務 (%) | 8,907.035 | 5,660.638 | 129,661.467 | 741.648 | 7,076.587 |
| 股東權益/負債合計 (%) | 1,373.743 | 1,290.864 | 2,092.776 | 345.234 | 608.329 |
| 利息保障倍數 (X) | -12.134 | -12.503 | -21.210 | 43.167 | 26.675 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 108.645 | 100.940 | 86.132 | 65.545 | 63.461 |
| 存貨周轉天數 (天) | 253.908 | 218.244 | 219.281 | 140.335 | 120.478 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 18/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
